◆ Contrarian Corpus
Campaigns / Citron Research → Apellis Pharmaceuticals
Citron Research vs. Apellis Pharmaceuticals

Apellis Pharmaceuticals · APLS

1 deck published between 2023-11-06 and 2023-11-06 — 13 pages, 13 analysed slides total.

initial thesis

Timeline

Each deck in chronological order — click to open. This is the story of the campaign as it unfolded.

  1. 2023-11-06 initial thesis

    2023 11 Citron Reports on Apellis Pharmaceuticals

    13pp · research_note

    Citron shorts Apellis, arguing its new Geographic Atrophy drug Syfovre faces an imminent FDA warning as AAO ophthalmologists reject it 83%-17% and vasculitis cases mount.